{"title":"Evaluation of Growth Status Using Serum IGF-I and IGFBP-3 in Children with Subclinical Hypothyroidism","authors":"J. Bae, B. Kwak, Sochung Chung","doi":"10.6065/JKSPE.2011.16.1.31","DOIUrl":null,"url":null,"abstract":"Purpose : The aim of this study was to evaluate growth status using the insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations in children with subclinical hypothyroidism (SCH). Methods : The study included 93 SCH patients (33 males and 60 females, age 8.1±1.9 years) and 94 healthy control subjects (31 males and 63 females, age 8.0±0.7 years). Patients’ height and weight were measured, and their body mass index (BMI) and Z-scores were calculated. The relationship between growth parameters, including IGF-I and IGFBP-3 concentrations and thyroid functions (thyroid-stimulating hormone (TSH) and free thyroxine 4 (fT4) was explored. Results : Although weight and BMI were greater in SCH patients, the Z-score of height, weight and BMI, and serum IGF-I and IGFBP-3 levels in SCH children were not significantly different compared to the control. In SCH patients, TSH showed a negative correlation with weight Z-scores (r =-0.23, P =0.028) and BMI Z-scores (r =-0.21, P =0.048). FT4 showed a positive correlation with IGFBP-3. Conclusion : The positive correlation of fT4 and IGFBP-3 and the negative relationship between TSH and weight and BMI Z-scores in SCH children suggest that subnormal thyroid functions could be related to growth impairment. (J Korean Soc Pediatr Endocrinol 2011;16:31-37)","PeriodicalId":346664,"journal":{"name":"Journal of Korean Society of Pediatric Endocrinology","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2011-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Korean Society of Pediatric Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6065/JKSPE.2011.16.1.31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose : The aim of this study was to evaluate growth status using the insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) concentrations in children with subclinical hypothyroidism (SCH). Methods : The study included 93 SCH patients (33 males and 60 females, age 8.1±1.9 years) and 94 healthy control subjects (31 males and 63 females, age 8.0±0.7 years). Patients’ height and weight were measured, and their body mass index (BMI) and Z-scores were calculated. The relationship between growth parameters, including IGF-I and IGFBP-3 concentrations and thyroid functions (thyroid-stimulating hormone (TSH) and free thyroxine 4 (fT4) was explored. Results : Although weight and BMI were greater in SCH patients, the Z-score of height, weight and BMI, and serum IGF-I and IGFBP-3 levels in SCH children were not significantly different compared to the control. In SCH patients, TSH showed a negative correlation with weight Z-scores (r =-0.23, P =0.028) and BMI Z-scores (r =-0.21, P =0.048). FT4 showed a positive correlation with IGFBP-3. Conclusion : The positive correlation of fT4 and IGFBP-3 and the negative relationship between TSH and weight and BMI Z-scores in SCH children suggest that subnormal thyroid functions could be related to growth impairment. (J Korean Soc Pediatr Endocrinol 2011;16:31-37)
目的:本研究的目的是利用胰岛素样生长因子- i (IGF-I)和igf结合蛋白-3 (IGFBP-3)浓度评估亚临床甲状腺功能减退症(SCH)患儿的生长状况。方法:纳入93例SCH患者(男33例,女60例,年龄8.1±1.9岁)和94例健康对照(男31例,女63例,年龄8.0±0.7岁)。测量患者身高、体重,计算体重指数(BMI)和z分数。探讨生长参数(包括IGF-I和IGFBP-3浓度)与甲状腺功能(促甲状腺激素(TSH)和游离甲状腺素4 (fT4))的关系。结果:SCH患儿体重、BMI均高于对照组,但SCH患儿身高、体重、BMI Z-score及血清IGF-I、IGFBP-3水平与对照组比较差异无统计学意义。SCH患者TSH与体重z -评分呈负相关(r =-0.23, P =0.028), BMI z -评分呈负相关(r =-0.21, P =0.048)。FT4与IGFBP-3呈正相关。结论:SCH患儿fT4与IGFBP-3呈正相关,TSH与体重、BMI z -score呈负相关,提示甲状腺功能亚正常可能与生长障碍有关。(韩国社会儿科内分泌杂志2011;16:31-37)